191 related articles for article (PubMed ID: 31576470)
1. Metabolomics as a potential method for predicting thyroid malignancy in children and adolescents.
Zhou Q; Zhang LY; Xie C; Zhang ML; Wang YJ; Liu GH
Pediatr Surg Int; 2020 Feb; 36(2):145-153. PubMed ID: 31576470
[TBL] [Abstract][Full Text] [Related]
2. Serum-plasma matched metabolomics for comprehensive characterization of benign thyroid nodule and papillary thyroid carcinoma.
Huang FQ; Li J; Jiang L; Wang FX; Alolga RN; Wang MJ; Min WJ; Ma G; Zhao YJ; Wang SL; Yu Y; Chen X; Zhu D; Zhu J; Wang G; Xia T; Sang JF; Lai MD; Li P; Zhu W; Qi LW
Int J Cancer; 2019 Feb; 144(4):868-876. PubMed ID: 30318614
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up for patients with papillary thyroid carcinoma treated as benign nodules.
Ito Y; Higashiyama T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Miyauchi A
Anticancer Res; 2007; 27(2):1039-43. PubMed ID: 17465240
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of HBME-1 and galectin-3 in the differential diagnosis of follicular-derived thyroid nodules.
Abd-El Raouf SM; Ibrahim TR
Pathol Res Pract; 2014 Dec; 210(12):971-8. PubMed ID: 25041837
[TBL] [Abstract][Full Text] [Related]
5. McGill Thyroid Nodule Score in Differentiating Benign and Malignant Pediatric Thyroid Nodules: A Pilot Study.
Canfarotta M; Moote D; Finck C; Riba-Wolman R; Thaker S; Lerer TJ; Payne RJ; Cote V
Otolaryngol Head Neck Surg; 2017 Oct; 157(4):589-595. PubMed ID: 28653562
[TBL] [Abstract][Full Text] [Related]
6. Elastic light-scattering spectroscopy for discrimination of benign from malignant disease in thyroid nodules.
Suh H; A'amar O; Rodriguez-Diaz E; Lee S; Bigio I; Rosen JE
Ann Surg Oncol; 2011 May; 18(5):1300-5. PubMed ID: 21174158
[TBL] [Abstract][Full Text] [Related]
7. Proton magnetic resonance and human thyroid neoplasia. II: Potential avoidance of surgery for benign follicular neoplasms.
Delbridge L; Lean CL; Russell P; May GL; Roman S; Dowd S; Reeve TS; Mountford CE
World J Surg; 1994; 18(4):512-6; discussion 516-7. PubMed ID: 7725737
[TBL] [Abstract][Full Text] [Related]
8. Papillary thyroid carcinoma with desmoid-type fibromatosis: A clinical, pathological, and immunohistochemical study of 14 cases.
Takada N; Hirokawa M; Ito M; Ito A; Suzuki A; Higuchi M; Kuma S; Hayashi T; Kishikawa M; Horikawa S; Miyauchi A
Endocr J; 2017 Oct; 64(10):1017-1023. PubMed ID: 28794344
[TBL] [Abstract][Full Text] [Related]
9. Pediatric thyroid nodules: A single center experience.
Trahan J; Reddy A; Chang E; Gomez R; Prasad P; Jeyakumar A
Int J Pediatr Otorhinolaryngol; 2016 Aug; 87():94-7. PubMed ID: 27368451
[TBL] [Abstract][Full Text] [Related]
10. Digital image-assisted quantitative nuclear analysis improves diagnostic accuracy of thyroid fine-needle aspiration cytology.
Chain K; Legesse T; Heath JE; Staats PN
Cancer Cytopathol; 2019 Aug; 127(8):501-513. PubMed ID: 31150162
[TBL] [Abstract][Full Text] [Related]
11. NMR-based metabolomics to select a surgical method for treating papillary thyroid carcinoma.
Wang B; Zhang LY; Wang SS; Yang YH; Zhao WX
Clinics (Sao Paulo); 2018 Nov; 73():e333. PubMed ID: 30462753
[TBL] [Abstract][Full Text] [Related]
12. Cost analysis of thyroid lobectomy and intraoperative frozen section versus total thyroidectomy in patients with a cytologic diagnosis of "suspicious for papillary thyroid cancer".
Leiker AJ; Yen TW; Cheung K; Evans DB; Wang TS
Surgery; 2013 Dec; 154(6):1307-13; discussion 1313-4. PubMed ID: 24238049
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical Subcellular Localization of Protein Biomarkers Distinguishes Benign from Malignant Thyroid Nodules: Potential for Fine-Needle Aspiration Biopsy Clinical Application.
Ralhan R; Veyhl J; Chaker S; Assi J; Alyass A; Jeganathan A; Somasundaram RT; MacMillan C; Freeman J; Vescan AD; Witterick IJ; Walfish PG
Thyroid; 2015 Nov; 25(11):1224-34. PubMed ID: 26131603
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Accuracy of Fine Needle Aspiration in Thyroid Nodules Arising in Patients with Graves Disease.
Hang JF; Lilo MT; Bishop JA; Ali SZ
Acta Cytol; 2017; 61(2):117-124. PubMed ID: 28259878
[TBL] [Abstract][Full Text] [Related]
15. Altered Serum MicroRNA Profile May Serve as an Auxiliary Tool for Discriminating Aggressive Thyroid Carcinoma from Nonaggressive Thyroid Cancer and Benign Thyroid Nodules.
Zhang A; Wang C; Lu H; Chen X; Ba Y; Zhang C; Zhang CY
Dis Markers; 2019; 2019():3717683. PubMed ID: 31636734
[TBL] [Abstract][Full Text] [Related]
16. Pediatric thyroid nodules: insights in management.
Lugo-Vicente H; Ortíz VN
Bol Asoc Med P R; 1998; 90(4-6):74-8. PubMed ID: 9866271
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of post-surgical fine-needle aspiration biopsies of thyroid lesions with indeterminate cytology using HRMAS NMR-based metabolomics.
Rezig L; Servadio A; Torregrossa L; Miccoli P; Basolo F; Shintu L; Caldarelli S
Metabolomics; 2018 Oct; 14(10):141. PubMed ID: 30830426
[TBL] [Abstract][Full Text] [Related]
18. The natural history of the benign thyroid nodule: what is the appropriate follow-up strategy?
Ajmal S; Rapoport S; Ramirez Batlle H; Mazzaglia PJ
J Am Coll Surg; 2015 Jun; 220(6):987-92. PubMed ID: 25667137
[TBL] [Abstract][Full Text] [Related]
19. Metabolic changes associated with papillary thyroid carcinoma: A nuclear magnetic resonance-based metabolomics study.
Li Y; Chen M; Liu C; Xia Y; Xu B; Hu Y; Chen T; Shen M; Tang W
Int J Mol Med; 2018 May; 41(5):3006-3014. PubMed ID: 29484373
[TBL] [Abstract][Full Text] [Related]
20. Utility of high b-value (2000 sec/mm2) DWI with RESOLVE in differentiating papillary thyroid carcinomas and papillary thyroid microcarcinomas from benign thyroid nodules.
Wang Q; Guo Y; Zhang J; Shi L; Ning H; Zhang X; Lu Y
PLoS One; 2018; 13(7):e0200270. PubMed ID: 30020961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]